Bronxville, NY, United States of America

Amit Verma

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Albert Einstein College of Medicine. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amit Verma. Retrieved from https://idiyas.com/inventor/amit-verma-e5k1odsi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amit Verma: Innovator in Cancer Treatment

Introduction

Amit Verma is a notable inventor based in Bronxville, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of acute myeloid leukemia and myelodysplastic syndromes. His innovative approaches have the potential to improve diagnosis, prognosis, and therapy for patients suffering from these conditions.

Latest Patents

Amit Verma holds a patent for the "Treatment of acute myeloid leukemia and myelodysplastic syndromes." This patent discloses methods for diagnosis, prognosis, and therapy using interleukin 1 receptor accessory protein and other targets. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Amit Verma is affiliated with the Albert Einstein College of Medicine, where he continues to work on groundbreaking research. His role at this prestigious institution allows him to collaborate with other experts in the field and contribute to the advancement of cancer treatment.

Collaborations

Some of his notable coworkers include Ulrich G Steidl and Laura Barreyro De Pujato. Their collaborative efforts enhance the research environment and foster innovation in cancer therapies.

Conclusion

Amit Verma's work in the treatment of acute myeloid leukemia and myelodysplastic syndromes exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for improved patient outcomes and advancing the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…